XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Coty Inc. Stockholders’ Equity
Preferred Stock
Common Stock
Class A Common Stock
Stock to be issued
Additional Paid-in Capital
Receivable from sale of stock
(Accumulated Deficit)
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Jun. 30, 2023     1.0                
Balance, beginning of period at Jun. 30, 2023 $ 3,997.4 $ 3,811.1 $ 0.0 $ 9.1 $ 0.0 $ 10,898.6 $ 0.0 $ (4,987.9) $ (662.4) $ (1,446.3) $ 186.3
Beginning balance (in shares) at Jun. 30, 2023       919.3              
Beginning balance (in shares) at Jun. 30, 2023                   66.5  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of Class A Common Stock in connection with global offering, net of offering costs (in shares)       30.0              
Issuance of Class A Common Stock in connection with global offering, net of offering costs (5.5) (5.5)   $ 0.3 31.5 311.2 (348.5)        
Exercise of employee stock options and restricted stock units (in shares)       5.2              
Exercise of employee stock options and restricted stock units       $ 0.1   (0.1)          
Shares withheld for employee taxes (0.8) (0.8)       (0.8)          
Share-based compensation expense 30.2 30.2       30.2          
Equity Investment contribution for share-based compensation 0.7 0.7       0.7          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income 2.7 1.6           1.6     1.1
Other comprehensive income (loss) (115.0) (115.0)             (115.0)    
Adjustment of redeemable noncontrolling interests to redemption value 2.3 2.3       2.3          
Ending balance (in shares) at Sep. 30, 2023     1.0                
Ending balance at Sep. 30, 2023 3,908.7 3,721.3 $ 0.0 $ 9.5 31.5 11,238.8 (348.5) (4,986.3) (777.4) $ (1,446.3) 187.4
Ending balance (in shares) at Sep. 30, 2023       954.5              
Ending balance (in shares) at Sep. 30, 2023                   66.5  
Balance, beginning of period at Jun. 30, 2023 93.5                    
Balance, beginning of period at Jun. 30, 2023 142.4                    
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 7.5                    
Other comprehensive loss (income) (0.1)                    
Adjustment of redeemable noncontrolling interests to redemption value (2.3)                    
Balance, end of period at Sep. 30, 2023 98.6                    
Balance, end of period at Sep. 30, 2023 142.4                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of Class A Common Stock in connection with global offering, net of offering costs (in shares)       3.0              
Issuance of Class A Common Stock in connection with global offering, net of offering costs 347.9 347.9     (31.5) 30.9 348.5        
Reacquired Class A Common Stock for employee taxes (in shares)                   0.1  
Exercise of employee stock options and restricted stock units (in shares)       4.2              
Exercise of employee stock options and restricted stock units 11.3 11.3   $ 0.1   11.2          
Shares withheld for employee taxes (17.3) (17.3)       (17.3)          
Share-based compensation expense 19.9 19.9       19.9          
Equity Investment contribution for share-based compensation 0.6 0.6       0.6          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income 181.4 180.9           180.9     0.5
Other comprehensive income (loss) 170.8 170.8             170.8    
Adjustment of redeemable noncontrolling interests to redemption value (7.3) (7.3)       (7.3)          
Ending balance (in shares) at Dec. 31, 2023     1.0                
Ending balance at Dec. 31, 2023 4,612.7 4,424.8 $ 0.0 $ 9.6 0.0 11,273.5 0.0 (4,805.4) (606.6) $ (1,446.3) 187.9
Ending balance (in shares) at Dec. 31, 2023       961.7              
Ending balance (in shares) at Dec. 31, 2023                   66.6  
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 4.6                    
Other comprehensive loss (income) 0.2                    
Distribution to noncontrolling interests, net (8.5)                    
Adjustment of redeemable noncontrolling interests to redemption value 7.3                    
Balance, end of period at Dec. 31, 2023 102.2                    
Balance, end of period at Dec. 31, 2023 142.4                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Repurchase of Class A Common Stock pursuant to forward repurchase contracts (in shares)                   27.0  
Repurchase of Class A Common Stock pursuant to forward repurchase contracts (350.6) (350.6)               $ (350.6)  
Reacquired Class A Common Stock for employee taxes (in shares)                   0.6  
Exercise of employee stock options and restricted stock units (in shares)       0.4              
Exercise of employee stock options and restricted stock units 2.3 2.3       2.3          
Shares withheld for employee taxes (1.0) (1.0)       (1.0)          
Share-based compensation expense 20.2 20.2       20.2          
Equity Investment contribution for share-based compensation 0.5 0.5       0.5          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income 6.2 3.8           3.8     2.4
Other comprehensive income (loss) (106.1) (106.0)             (106.0)   (0.1)
Distribution to noncontrolling interests, net (1.0)                   (1.0)
Adjustment of redeemable noncontrolling interests to redemption value 1.9 1.9       1.9          
Ending balance (in shares) at Mar. 31, 2024     1.0                
Ending balance at Mar. 31, 2024 4,181.8 3,992.6 $ 0.0 $ 9.6 $ 0.0 11,294.1 $ 0.0 (4,801.6) (712.6) $ (1,796.9) 189.2
Ending balance (in shares) at Mar. 31, 2024       962.1              
Ending balance (in shares) at Mar. 31, 2024                   94.2  
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 2.6                    
Other comprehensive loss (income) (0.1)                    
Distribution to noncontrolling interests, net (8.6)                    
Adjustment of redeemable noncontrolling interests to redemption value (1.9)                    
Balance, end of period at Mar. 31, 2024 94.2                    
Balance, end of period at Mar. 31, 2024 $ 142.4                    
Beginning balance (in shares) at Jun. 30, 2024 1.0   1.0                
Balance, beginning of period at Jun. 30, 2024 $ 4,011.7 3,827.1 $ 0.0 $ 9.6   11,308.0   (4,898.5) (795.1) $ (1,796.9) 184.6
Beginning balance (in shares) at Jun. 30, 2024 962.1     962.1              
Beginning balance (in shares) at Jun. 30, 2024 94.3                 94.3  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense $ 16.9 16.9       16.9          
Equity Investment contribution for share-based compensation 0.4 0.4       0.4          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income 85.0 82.9           82.9     2.1
Other comprehensive income (loss) 120.6 120.6             120.6    
Adjustment of redeemable noncontrolling interests to redemption value 0.6 0.6       0.6          
Ending balance (in shares) at Sep. 30, 2024     1.0                
Ending balance at Sep. 30, 2024 4,231.9 4,045.2 $ 0.0 $ 9.6   11,322.6   (4,815.6) (674.5) $ (1,796.9) 186.7
Ending balance (in shares) at Sep. 30, 2024       962.1              
Ending balance (in shares) at Sep. 30, 2024                   94.3  
Balance, beginning of period at Jun. 30, 2024 93.6                    
Balance, beginning of period at Jun. 30, 2024 142.4                    
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 5.7                    
Other comprehensive loss (income) 0.1                    
Adjustment of redeemable noncontrolling interests to redemption value (0.6)                    
Balance, end of period at Sep. 30, 2024 98.8                    
Balance, end of period at Sep. 30, 2024 142.4                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of employee stock options and restricted stock units (in shares)       4.2              
Shares withheld for employee taxes (12.7) (12.7)       (12.7)          
Share-based compensation expense 15.2 15.2       15.2          
Equity Investment contribution for share-based compensation 0.3 0.3       0.3          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income 25.3 23.7           23.7     1.6
Other comprehensive income (loss) (284.7) (284.5)             (284.5)   (0.2)
Distribution to noncontrolling interests, net (3.9)                   (3.9)
Adjustment of redeemable noncontrolling interests to redemption value 0.8 0.8       0.8          
Ending balance (in shares) at Dec. 31, 2024     1.0                
Ending balance at Dec. 31, 2024 3,968.9 3,784.7 $ 0.0 $ 9.6   11,322.9   (4,791.9) (959.0) $ (1,796.9) 184.2
Ending balance (in shares) at Dec. 31, 2024       966.3              
Ending balance (in shares) at Dec. 31, 2024                   94.3  
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 5.3                    
Other comprehensive loss (income) (0.2)                    
Adjustment of redeemable noncontrolling interests to redemption value (0.8)                    
Balance, end of period at Dec. 31, 2024 103.1                    
Balance, end of period at Dec. 31, 2024 142.4                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of employee stock options and restricted stock units (in shares)       0.2              
Shares withheld for employee taxes (0.3) (0.3)       (0.3)          
Share-based compensation expense 12.6 12.6       12.6          
Equity Investment contribution for share-based compensation (0.1) (0.1)       (0.1)          
Dividends Accrued - Convertible Series B Preferred Stock (3.3) (3.3)       (3.3)          
Net income (403.7) (405.7)           (405.7)     2.0
Other comprehensive income (loss) 118.2 118.2             118.2    
Distribution to noncontrolling interests, net (6.0)                   (6.0)
Adjustment of redeemable noncontrolling interests to redemption value $ (11.1) (11.1)       (11.1)          
Ending balance (in shares) at Mar. 31, 2025 1.0   1.0                
Ending balance at Mar. 31, 2025 $ 3,675.2 $ 3,495.0 $ 0.0 $ 9.6   $ 11,320.7   $ (5,197.6) $ (840.8) $ (1,796.9) $ 180.2
Ending balance (in shares) at Mar. 31, 2025 966.5     966.5              
Ending balance (in shares) at Mar. 31, 2025 94.3                 94.3  
Redeemable Noncontrolling Interests                      
Dividends Accrued - Convertible Series B Preferred Stock $ 3.3                    
Dividends Paid - Convertible Series B Preferred Stock (3.3)                    
Net income 1.5                    
Other comprehensive loss (income) 0.2                    
Distribution to noncontrolling interests, net (14.0)                    
Adjustment of redeemable noncontrolling interests to redemption value 11.1                    
Balance, end of period at Mar. 31, 2025 101.9                    
Balance, end of period at Mar. 31, 2025 $ 142.4